Is It Safe for the Elderly to Take Gabapentin?

Gabapentin is one of the most widely prescribed medications among older adults, yet its safety profile in this population is far from straightforward. The drug is not outright dangerous for every older person, but it carries specific risks that intensify with age, reduced kidney function, and certain common co-prescriptions. These risks are serious enough that the American Geriatrics Society’s Beers Criteria, a widely used guide to medications that may be inappropriate for older adults, recommends caution or avoidance under certain circumstances. Whether gabapentin is safe for a particular older person depends heavily on the dose, what else they take, and how well their kidneys work.

Why So Many Older Adults Take Gabapentin

Gabapentin was originally approved for epilepsy and postherpetic neuralgia, the nerve pain that lingers after a shingles outbreak. In practice, though, those approved uses account for a vanishingly small share of actual prescriptions. A study of Medicare beneficiaries found that among people who started gabapentin, fewer than 0.5% had epilepsy or postherpetic neuralgia documented as their condition. The most common reason was chronic pain, present in about a third of new users. Overall, gabapentin prescribing among Medicare enrollees climbed from roughly 7% in 2013 to over 10% by 2021.¹

This surge partly reflects a well-intentioned effort to move away from opioids for pain management. Gabapentin seemed like a safer alternative, and for some patients it is. But the rapid growth in prescribing also means many older adults are taking gabapentin for conditions where the evidence of benefit is thin, while still being exposed to the drug’s side effects. The average age of new gabapentin users in the Medicare data was about 76, and roughly six in ten were women.¹

How Aging Changes What Gabapentin Does in the Body

Gabapentin is unusual among medications because it is not broken down by the liver. Instead, it passes through the kidneys essentially unchanged. That makes kidney function the single most important factor determining how much gabapentin accumulates in an older person’s body. Since kidney function naturally declines with age, older adults clear the drug more slowly, and blood levels can climb higher than intended on a dose that would be unremarkable in a younger person.

A pharmacokinetic study of gabapentin in nursing home residents confirmed that the drug’s clearance was tightly linked to estimated kidney filtration rate. Once that kidney effect was accounted for, age itself, sex, body weight, and other health burdens did not independently change how the drug was handled.² The practical takeaway is clear: a standard adult dose of gabapentin can become an effective overdose in someone whose kidneys have quietly slowed down, which describes a large share of people over 70 even if they feel perfectly healthy.

Falls and Fractures

Falls are the leading cause of injury-related death in older adults, and any medication that causes dizziness or unsteadiness deserves close scrutiny. Gabapentin has long been flagged for increasing fall risk, and the evidence from large studies bears that concern out, though the picture is a bit more nuanced than “gabapentin causes broken hips.”

A case-crossover study published in JAMA Network Open looked at older adults who were hospitalized with hip fractures and compared their recent gabapentinoid use to their own use several months earlier. After adjusting for the general trend of increasing prescriptions over time and for other sedating medications, gabapentinoid dispensing was associated with about a 30% increase in the odds of hip fracture.³

A multinational study published in The Lancet Healthy Longevity added a wrinkle. It found that the fracture risk was actually highest in the period just before gabapentinoid treatment started, and elevated in the first 60 days of use, but did not remain elevated over the longer treatment period. The researchers concluded that the results do not support a sustained causal link between gabapentinoid use and fractures but do warrant fall-prevention measures around the time treatment begins.⁴

What does that mean in practice? The underlying pain condition that prompts the prescription may itself increase fall risk, so it is hard to cleanly separate the drug’s contribution from the disease’s. Still, the early weeks of gabapentin use appear to be a particularly vulnerable window. During that period, a lower starting dose, a slower increase, and extra attention to home safety all make sense.

Confusion and Altered Mental Status

Dizziness, drowsiness, fatigue, and confusion are among the most commonly reported side effects of gabapentin in older adults.⁵ These are not just annoyances. In a frail older person, sedation can trigger a cascade: a confused patient who cannot think clearly is more likely to fall, less likely to eat and drink, and more likely to end up in the hospital.

A large retrospective study examined over 110,000 older adults who started gabapentin and compared those initiated on higher doses to those started on lower doses. Starting at a higher dose was associated with about a 29% increase in the risk of hospitalization for altered mental status within 30 days. The absolute risk was modest, roughly 1.3% versus 1.1%, but in a population that numbers in the millions, that small percentage translates to a meaningful number of preventable hospital admissions.⁶

This is one of the clearest arguments for starting low and going slow. The difference in confusion risk between a cautious starting dose and a standard one is real and measurable, and the higher dose does not appear to offer a compensating survival benefit. In the same study, there was no statistically significant increase in 30-day mortality between the high-dose and low-dose groups.⁶

The Opioid Combination Problem

If there is one scenario where gabapentin in older adults crosses from “use with caution” into genuinely alarming territory, it is when the drug is combined with opioids. This combination has become common precisely because clinicians hoped gabapentin would let them prescribe lower opioid doses. But the two drugs amplify each other’s sedating effects, and both can suppress breathing.

A large nested case-control study spanning more than 16 years found that co-prescribing gabapentin with opioids was associated with roughly a 50% increase in the risk of dying from opioid-related causes compared to opioids alone, after adjusting for other factors. At very high gabapentin doses, the risk nearly doubled.⁷ The mechanism involves both additive respiratory depression and a pharmacokinetic quirk: opioids appear to increase how much gabapentin the gut absorbs, pushing blood levels higher than expected.⁷

This risk is serious enough that the updated Beers Criteria now recommend avoiding gabapentinoids in combination with opioids in older adults because of the risk of sedation, respiratory depression, and death.⁸ Gabapentin can also cause respiratory depression on its own, a particular concern in vulnerable populations such as older adults with sleep apnea or lung disease.⁹

Dosing for Older Adults

Because kidney function is so central to gabapentin safety, dosing in older adults should always account for how well the kidneys are working. Clinicians typically use a measure called creatinine clearance to guide this. The general approach is to start at a low dose and increase gradually, giving the body time to adjust and the prescriber time to watch for side effects. In older adults, titration should proceed more slowly than in younger patients.

Recommended dose ceilings based on kidney function look roughly like this:

Mild impairment: maximum around 1,800 mg per day, split into three doses.
Moderate impairment: maximum around 900 mg per day, split into two or three doses.
More advanced impairment: maximum around 300 to 600 mg per day, often given once daily.
On dialysis: a supplemental dose after each session, typically in the range of 100 to 300 mg.

Starting doses are usually 100 to 300 mg total per day, with increases of 100 to 300 mg every one to three days in younger adults but more slowly in older ones.¹⁰ A common mistake is to prescribe a dose appropriate for a younger adult’s kidneys and assume it will be fine. Even older adults whose kidney function tests look borderline normal may be clearing the drug significantly more slowly than expected.

Drug Interactions Beyond Opioids

Gabapentin has a relatively clean interaction profile with most medications because it bypasses liver metabolism entirely. It does not go through the enzyme systems that cause so many drug-drug interactions with other medications. That is one of its genuine advantages for older adults, who often take long lists of medications processed by the liver.

One interaction that does matter involves magnesium-containing antacids. A study in healthy adults found that taking gabapentin together with magnesium oxide reduced gabapentin absorption by roughly a third. The culprit appeared to be the magnesium itself interfering with gut absorption rather than any change in stomach acid. In contrast, omeprazole, a common acid-suppressing medication, did not affect gabapentin levels at all.¹¹ Since many older adults regularly use antacids for heartburn or as calcium-magnesium supplements, this interaction can quietly make gabapentin less effective. The simple fix is to separate the doses by at least two hours.

People with Existing Cognitive Impairment

A question that comes up often in clinical practice is whether gabapentin is safe for someone who already has mild cognitive impairment or early dementia. A study that tracked research participants with cognitive impairment found that starting gabapentin was not associated with measurable worsening of cognitive or functional scores over one to two years of follow-up. It was, however, associated with roughly double the odds of new falls at the two-year mark.¹²

That is a mixed finding. On one hand, gabapentin does not seem to accelerate the underlying cognitive decline, which is reassuring. On the other, the population already most prone to falls sees their fall risk increase further. For someone with cognitive impairment, the decision to use gabapentin has to weigh the benefit of pain relief or seizure control against the very real chance of a fall that could lead to a hip fracture, hospitalization, and further functional decline.

Withdrawal Is Real

Gabapentin is sometimes described as a low-risk medication that can be stopped easily, but that is not always true. Physical dependence can develop, and abrupt discontinuation or even a too-rapid taper can produce withdrawal symptoms. A case report documented a patient who, even with a gradual taper, developed worsening symptoms including severe mental status changes, chest pain, and high blood pressure about ten days after stopping gabapentin. Restarting the drug resolved the symptoms within a day or two.¹³

The deprescribing literature is still thin. A scoping review of interventions aimed at reducing or stopping gabapentinoids in adults found that in the available randomized trials, at least a third of participants were able to stop the drug entirely. But the review also noted a lack of long-term follow-up data and no studies incorporating psychological support into the tapering process.¹⁴ If you or a family member want to stop gabapentin, the evidence strongly favors a slow, supervised taper over stopping cold turkey.

Gabapentin Versus Pregabalin

Pregabalin is gabapentin’s close pharmacological cousin, and prescribers sometimes consider switching between the two. A systematic review and meta-analysis comparing the two drugs for neuropathic pain found no significant difference in the overall rate of side effects. However, gabapentin was associated with more nausea and vomiting than pregabalin, while the two drugs caused dizziness and drowsiness at similar rates.¹⁵ For older adults, the key difference is that pregabalin is absorbed more predictably. Gabapentin has a saturable absorption mechanism, meaning that above a certain dose, more drug does not lead to proportionally higher blood levels. This makes gabapentin dosing somewhat less predictable at high doses compared to pregabalin, though it also provides a natural ceiling on absorption that can act as a safety buffer. Both drugs share the same concerns regarding falls, sedation, and respiratory depression when combined with opioids.

Driving and Daily Activities

Gabapentin’s sedating effects raise practical questions about activities like driving. A review of drugged-driving cases found that in the small number of cases where gabapentin was the only drug detected, the observed impairments were consistent with the drug’s known side effects: drowsiness, slowed reaction time, and poor coordination. Half of those single-drug cases involved crashes where the driver was at fault. In the broader dataset, the vast majority of gabapentin-involved driving cases also involved other drugs, making it hard to isolate gabapentin’s contribution.¹⁶

For older adults, the practical implication extends beyond driving. Gabapentin-induced drowsiness and unsteadiness can impair the ability to safely navigate stairs, manage household tasks, or react quickly to hazards. These effects tend to be most pronounced in the first few weeks of treatment or after a dose increase, which aligns with the fracture data showing the highest risk in the early treatment period. If you are starting gabapentin or increasing the dose, avoid driving or other demanding tasks until you know how the drug affects you, and consider asking someone to check on you regularly during the adjustment period.

What Caregivers Should Watch For

If you are caring for an older family member who takes gabapentin, the most important things to monitor are mental status changes and unsteadiness. Confusion, unusual drowsiness, slurred speech, or a new tendency to stumble are all signals that the dose may be too high or that the kidneys are not clearing the drug fast enough. These symptoms are easy to mistake for normal aging or progression of an underlying condition like dementia, which is part of what makes them dangerous.

It also helps to keep an updated list of all medications and supplements, since the opioid interaction is the most dangerous scenario and the antacid interaction is the most commonly overlooked. If your family member’s kidney function has been tested recently, knowing the result can help the prescribing clinician choose the right dose. And if gabapentin was started for a condition that has improved or resolved, it is worth asking whether the drug is still needed at all. Given how often gabapentin is prescribed off-label for conditions with limited supporting evidence, a periodic reassessment of whether the benefit still outweighs the risk is one of the most valuable things a caregiver can advocate for.

1
PubMed Central. Patterns and Characteristics of Gabapentin Use Among Medicare Beneficiaries
2
PubMed Central. Pharmacokinetics and Saturable Absorption of Gabapentin in Nursing Home Elderly Patients
3
JAMA Network Open. Gabapentinoids and Risk of Hip Fracture
4
The Lancet Healthy Longevity. Risk of fracture with gabapentinoid treatment in older adults: a multinational population-based study
5
PubMed Central. The association between Gabapentin or Pregabalin use and the risk of dementia: an analysis of the National Health Insurance Research Database in Taiwan
6
PubMed Central. Gabapentin dose and the 30-day risk of altered mental status in older adults: A retrospective population-based study
7
PubMed Central. Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case–control study
8
PharmD Live. Is It Safe for the Elderly to Take Gabapentin? – Section: Newly Added Medications Include:
9
PubMed Central. Concurrent Gabapentin and Opioid Use and Risk of Mortality in Medicare Recipients with Non-Cancer Pain
10
PubMed Central. Gabapentin for Neuropathic Pain – Section: Dosing in renal impairment
11
PubMed. Impact of concomitant antacid administration on gabapentin plasma exposure and oral bioavailability in healthy adult subjects
12
Alzheimer’s & Dementia. Gabapentin initiation and neurocognitive changes in older adults with cognitive impairment
13
PubMed. Gabapentin withdrawal syndrome in the presence of a taper
14
PubMed. Deprescribing interventions for gabapentinoids in adults: A scoping review
15
PubMed Central. Pregabalin vs. gabapentin in the treatment of neuropathic pain: a comprehensive systematic review and meta-analysis of effectiveness and safety
16
PubMed. Gabapentin in drugged driving investigations